These findings may have implications for CKLF1 as an important mediator in occurrence of cardiopulmonary complications after ischemic stroke, and also provide new ideas for drug development on ischemic stroke, especially the stroke induced cardiopulmonary complications therapy. The gene discussed is CKLF; the disease is Stroke.